DESAI, S. Cysteamine: Clinical efficacy, safety and tolerability versus best-in-class treatments for melasma . SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 6, p. s88, 2021. DOI: 10.25251/skin.5.supp.88. Disponível em: https://jofskin.org/index.php/skin/article/view/1439. Acesso em: 10 aug. 2022.